Literature DB >> 11086081

Three-dimensional structure of the Fab from a human IgM cold agglutinin.

A Cauerhff1, B C Braden, J G Carvalho, R Aparicio, I Polikarpov, J Leoni, F A Goldbaum.   

Abstract

Cold agglutinins (CAs) are IgM autoantibodies characterized by their ability to agglutinate in vitro RBC at low temperatures. These autoantibodies cause hemolytic anemia in patients with CA disease. Many diverse Ags are recognized by CAs, most frequently those belonging to the I/i system. These are oligosaccharides composed of repeated units of N:-acetyllactosamine, expressed on RBC. The three-dimensional structure of the Fab of KAU, a human monoclonal IgM CA with anti-I activity, was determined. The KAU combining site shows an extended cavity and a neighboring pocket. Residues from the hypervariable loops V(H)CDR3, V(L)CDR1, and V(L)CDR3 form the cavity, whereas the small pocket is defined essentially by residues from the hypervariable loops V(H)CDR1 and V(H)CDR2. This fact could explain the V(H)4-34 germline gene restriction among CA. The KAU combining site topography is consistent with one that binds a polysaccharide. The combining site overall dimensions are 15 A wide and 24 A long. Conservation of key binding site residues among anti-I/i CAs indicates that this is a common feature of this family of autoantibodies. We also describe the first high resolution structure of the human IgM C(H)1:C(L) domain. The structural analysis shows that the C(H)1-C(L) interface is mainly conserved during the isotype switch process from IgM to IgG1.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11086081     DOI: 10.4049/jimmunol.165.11.6422

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Immunoglobulin heavy and light chain gene features are correlated with primary cold agglutinin disease onset and activity.

Authors:  Agnieszka Małecka; Gunhild Trøen; Anne Tierens; Ingunn Østlie; Jędrzej Małecki; Ulla Randen; Sigbjørn Berentsen; Geir E Tjønnfjord; Jan M A Delabie
Journal:  Haematologica       Date:  2016-05-19       Impact factor: 9.941

2.  Crystal structure of a glycosylated Fab from an IgM cryoglobulin with properties of a natural proteolytic antibody.

Authors:  Paul A Ramsland; Simon S Terzyan; Gwendolyn Cloud; Christina R Bourne; William Farrugia; Gordon Tribbick; H Mario Geysen; Carolyn R Moomaw; Clive A Slaughter; Allen B Edmundson
Journal:  Biochem J       Date:  2006-05-01       Impact factor: 3.857

3.  Cryomicroscopy reveals the structural basis for a flexible hinge motion in the immunoglobulin M pentamer.

Authors:  Qu Chen; Rajesh Menon; Lesley J Calder; Pavel Tolar; Peter B Rosenthal
Journal:  Nat Commun       Date:  2022-10-23       Impact factor: 17.694

4.  Crystal structure of a human autoimmune complex between IgM rheumatoid factor RF61 and IgG1 Fc reveals a novel epitope and evidence for affinity maturation.

Authors:  Stephane Duquerroy; Enrico A Stura; Stéphane Bressanelli; Stella M Fabiane; Marie C Vaney; Dennis Beale; Maureen Hamon; Paolo Casali; Felix A Rey; Brian J Sutton; Michael J Taussig
Journal:  J Mol Biol       Date:  2007-03-06       Impact factor: 5.469

5.  IgM Antibodies Can Access Cryptic Antigens Denied to IgG: Hypothesis on Novel Binding Mechanism.

Authors:  Eric Chun Yiu Law; Danny Tze Ming Leung; Frankie Chi Hang Tam; Kitty Kit Ting Cheung; Naomi Hua Yin Cheng; Pak Leong Lim
Journal:  Front Immunol       Date:  2019-08-02       Impact factor: 7.561

6.  Clonal redemption of autoantibodies by somatic hypermutation away from self-reactivity during human immunization.

Authors:  Joanne H Reed; Jennifer Jackson; Daniel Christ; Christopher C Goodnow
Journal:  J Exp Med       Date:  2016-06-13       Impact factor: 14.307

7.  Systematic screening of soluble expression of antibody fragments in the cytoplasm of E. coli.

Authors:  Anna Gaciarz; Johanna Veijola; Yuko Uchida; Mirva J Saaranen; Chunguang Wang; Sohvi Hörkkö; Lloyd W Ruddock
Journal:  Microb Cell Fact       Date:  2016-01-25       Impact factor: 5.328

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.